A comparison of semaglutide with real-world proteomic profiles revealed potential benefits on disease-specific proteomic signatures including the downregulation of specific proteins associated with cardiovascular disease risk, supporting its reported effects of lowering cardiovascular disease risk and potential drug repurposing opportunities
Retrieved from Azuri, J., Hammerman, A., Aboalhasan, E., et al
Be skeptical of high absorption hype: formulations like dihydroberberine and berberine phytosome have small human pharmacokinetic studies showing higher blood levels than standard berberine, but that does not automatically mean better real-world weight loss
TSA agents see injectable medications hundreds of times per day
Under-eating earlier in the day, then feeling more driven to eat at night
Promising new research on the horizon There is hope on the horizon regarding semaglutides role in preventing or treating Alzheimers disease